Public comment period · Evidence synthesis
Draft synthesis: Nationally registered neuropeptides and the retrievability of their evidence base
Consultation on the draft of this methodological review, which registers the question: For neuropeptides holding a national marketing registration outside the jurisdictions the Institute routinely reviews, what evidence is retrievable and what can be…
§1Consultation and window
§1.1Window
- Opened
- 19 October 2024
- Closed
- 30 November 2024
- Duration
- 42 days
- Status
- Closed — the disposition is published
- Document under consultation
- Synthesis: Nationally registered neuropeptides and the retrievability of their…
- Submissions received
- 16
§1.2Consultation questions
The secretariat put the following questions. A submission was not required to address them and several did not; the questions record what the Institute was uncertain about rather than restricting what a respondent could raise.
- Is the very low certainty rating for the anchor outcome correctly drawn from the contributing evidence?
- Is any eligible study missing from the included set, and is any included study ineligible under the registered criteria?
- Are the limitations recorded in the abstract sufficient, and is any material limitation omitted?
§1.3How a submission is handled
- Every submission is signed. The Institute publishes no anonymous submission.
- Every submission carries a declared interest. A declaration of no interest is itself a declaration and is recorded as one. A declaration is not a disqualification and the Institute has never given a submission less weight on that ground.
- A submission from an employee of a marketing-authorisation holder is identified as an industry submission on its face, following a unanimous consultation on the conflicts policy.
- Every submission receives a secretariat response and a disposition. Submissions that are not accepted remain published in full; the Institute does not remove a submission because it disagrees with it.
- There is no voting, no reputation score, no reply thread and no editing after receipt.
§1.4Outcome
Amendments arising were applied and are recorded in the review's amendment log, each traceable to a numbered submission.
The disposition table, listing each submission with its disposition and the resulting amendment, is at §3.
Compound Evidence Institute · CEI-CP-109 · https://compoundevidence.com/comment-periods/draft-russian-registered-neuropeptides-synthesis/ · retrieved 30 July 2026